Stryker (SYK) Q3 FY26 earnings call

Stryker's third quarter underscored divergent divisional dynamics, as robust double-digit demand in Endoscopy and OrthoTec was overshadowed by sharp market deceleration in large joint reconstruction. Management tempered full-year top-line and earnings outlooks as higher deductibles, insurance denials, and ERP transition friction restrained hip and knee procedural volumes. Operating margin discipline and expanding robotics applications continue to anchor execution.